The company will utilise the investment from KSSF II to set up a new manufacturing plant
Kotak Strategic Situations India Fund II (“KSSF II”), managed by Kotak Alternate Asset Managers (Kotak Alt), recently announced an investment of up to Rs 400 crore in Biorad Medisys.
Biorad Medisys is a leading medical device manufacturer. The Company will primarily utilise the investment from KSSF II to set up a new manufacturing plant, repay existing debt and fund increasing working capital requirements.
Jitendra Hegde, MD, Biorad Medisys said, “This investment marks a momentous occasion for us. We are excited to have an investor on board who shares our vision of transforming the Indian medical devices industry and has a strong pedigree and successful track record of investing in the healthcare sector in India.
- Advertisement -